[Efficiency of imatinib in polyserositis revealing a FIP1L1-PDGFRA-negative hypereosinophilic syndrome].

MLA

Green, L., et al. “[Efficiency of Imatinib in Polyserositis Revealing a FIP1L1-PDGFRA-Negative Hypereosinophilic Syndrome].” La Revue de Medecine Interne, vol. 31, no. 4, Apr. 2010, pp. 305–08. EBSCOhost, https://doi.org/10.1016/j.revmed.2009.08.005.

APA

Green, L., Kahn, J.-E., Dufour, J.-F., Le Scanff, J., Charhon, A., Broussolle, C., & Sève, P. (2010). [Efficiency of imatinib in polyserositis revealing a FIP1L1-PDGFRA-negative hypereosinophilic syndrome]. La Revue de Medecine Interne, 31(4), 305–308. https://doi.org/10.1016/j.revmed.2009.08.005

Chicago

Green, L, J-E Kahn, J-F Dufour, J Le Scanff, A Charhon, C Broussolle, and P Sève. 2010. “[Efficiency of Imatinib in Polyserositis Revealing a FIP1L1-PDGFRA-Negative Hypereosinophilic Syndrome].” La Revue de Medecine Interne 31 (4): 305–8. doi:10.1016/j.revmed.2009.08.005.